Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
iQure Pharma
company
About
iQure Pharma is a global biotech company that develops new therapeutics for patients and physicians.
- 1 - 10
Details
- Last Funding Type
- Grant
- Industries
- Biotechnology,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 2019
- Number Of Employee
- 1 - 10
- Operating Status
- Active
iQure Pharma is a global biotech company created by entrepreneurs and former pharma managers that focuses on the development of new therapeutics.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$600K
iQure Pharma has raised a total of
$600K
in funding over 2 rounds. Their latest funding was raised on
Aug 31, 2022 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 31, 2022 | Grant | — | 1 |
National Institutes of Health
|
— | Detail |
| Aug 31, 2022 | Series A | $600K | 2 |
Keiretsu Forum Mid Atlantic
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
2
3
iQure Pharma is funded by 3 investors.
National Institutes of Health
and Keiretsu Forum Mid Atlantic
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Institutes of Health
|
Yes | Grant |
|
Keiretsu Forum Mid Atlantic
|
Yes | Series A |
Keiretsu Forum
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
